ZipRecruiter

Log In

1

Biotech Hedge Fund Jobs (NOW HIRING)

Guidepoint

Strategist, Therapeutics

New York, NY · On-site

$200K - $220K/yr

... hedge fund), sell-side equity research analysts, and industry professionals. We are seeking a ... biotech/pharma sector. This role involves identifying timely and topical ideas, leading expert ...

Guidepoint

Strategist, Therapeutics

New York, NY

$200K - $220K/yr

... hedge fund), sell-side equity research analysts, and industry professionals. We are seeking a ... biotech/pharma sector. This role involves identifying timely and topical ideas, leading expert ...

Guidepoint

Senior Analyst -Therapeutics

New York, NY · On-site

$180K - $200K/yr

... hedge fund), sell-side equity research analysts, and industry professionals. We are seeking a ... biotech/pharma sector. This role involves identifying timely and topical ideas, leading expert ...

Guidepoint

Senior Analyst -Therapeutics

New York, NY · Hybrid

$180K - $200K/yr

... hedge fund), sell-side equity research analysts, and industry professionals. We are seeking a ... biotech/pharma sector. This role involves identifying timely and topical ideas, leading expert ...

Guidepoint

Senior Associate - Therapeutics

New York, NY · On-site

$90K - $100K/yr

... equity/hedge fund), sell-side equity research analysts, and industry professionals. This is a ... biotech and pharma sectors. * Lead interviews as a moderator featuring expert physicians ...

Guidepoint

Senior Associate - Therapeutics

New York, NY · Hybrid

$90K - $100K/yr

... equity/hedge fund), sell-side equity research analysts, and industry professionals. This is a ... biotech and pharma sectors. * Lead interviews as a moderator featuring expert physicians ...

HireNow Staffing

Applied AI Engineer

New York, NY · On-site +1

Prior fintech, hedge fund, institutional investment, biotech, or quantitative systems experience * Experience building AI-powered workflow automation tools or financial intelligence platforms

All JobsBiotech Hedge Fund Jobs

Biotech Hedge Fund information

See salary details

$11K

$77.9K

$122K

How much do biotech hedge fund jobs pay per year?

As of Jun 30, 2026, the average yearly pay for biotech hedge fund in the United States is $77,940.00, according to ZipRecruiter salary data. Most workers in this role earn between $51,000.00 and $100,000.00 per year, depending on experience, location, and employer.

What is a Biotech Hedge Fund job?

A Biotech Hedge Fund job involves analyzing and investing in biotechnology and pharmaceutical companies to generate returns for the fund. Professionals in this field typically have backgrounds in life sciences, finance, or both, and they assess drug pipelines, regulatory approvals, and market trends. Roles may include investment analysts, portfolio managers, or researchers who evaluate scientific and financial data to identify profitable opportunities. The work requires strong analytical skills, industry knowledge, and an understanding of financial markets.

What are some common challenges faced when working at a biotech hedge fund?

Professionals at a biotech hedge fund often navigate the unique complexity of evaluating scientific data while forecasting market trends and regulatory outcomes. Balancing the fast-paced demands of trading with deep-dive research into clinical pipelines can be demanding. Success in this role requires constant learning to stay ahead of new breakthroughs, regulatory changes, and competitive dynamics in both biotech and finance. Additionally, collaboration with analysts, portfolio managers, and scientific experts is critical, making strong communication skills essential. These challenges can be rewarding for those passionate about innovation and investment strategy.

How much do biotech hedge fund analysts make?

Biotech hedge fund analysts typically earn between $80,000 and $150,000 annually, with experienced professionals and those in senior roles earning higher salaries and bonuses. Compensation often includes performance-based bonuses and may vary based on fund size, location, and individual expertise in biotech research and financial analysis.

What are the top biotech hedge funds?

Biotech hedge funds are investment firms that focus on biotechnology companies, often employing specialized research and analysis to identify promising biotech stocks. Some well-known biotech hedge funds include Perceptive Advisors, Orbimed Advisors, and RA Capital Management, which are recognized for their expertise in biotech investments and active portfolio management.

What is the highest paying job in biotech?

In the biotech industry, senior executive roles such as Chief Scientific Officer (CSO) or Chief Executive Officer (CEO) tend to be the highest paid, often earning six- to seven-figure salaries including bonuses and stock options. These positions require extensive experience, leadership skills, and advanced scientific or business expertise. Other high-paying roles include senior research directors and specialized biotech investment professionals in hedge funds, who leverage scientific knowledge and financial acumen.

What does a biotech hedge fund do?

A biotech hedge fund invests in biotechnology companies and related assets to generate high returns through active trading strategies. Professionals in this field analyze scientific data, market trends, and company performance, often using financial modeling and research tools to make investment decisions.

What are the key skills and qualifications needed to thrive in the Biotech Hedge Fund position, and why are they important?

To thrive at a biotech hedge fund, you need strong analytical skills, in-depth knowledge of biotechnology and financial markets, and a degree in life sciences, finance, or a related field. Familiarity with financial modeling software, data analysis tools, and platforms such as Bloomberg Terminal is typically required, and credentials like the CFA can be advantageous. Effective communication, teamwork, and the ability to manage risk under pressure help professionals excel in this environment. These skills enable informed investment decisions and effective collaboration in a rapidly evolving sector where both scientific and financial expertise are crucial.

More about Biotech Hedge Fund jobs
What cities are hiring for Biotech Hedge Fund jobs? Cities with the most Biotech Hedge Fund job openings:
What are the most commonly searched types of Biotech Hedge Fund jobs? The most popular types of Biotech Hedge Fund jobs are:
What states have the most Biotech Hedge Fund jobs? States with the most job openings for Biotech Hedge Fund jobs include:
What job categories do people searching Biotech Hedge Fund jobs look for? The top searched job categories for Biotech Hedge Fund jobs are:
Biotech Hedge Fund jobs near you
Infographic showing various Biotech Hedge Fund job openings in the United States as of June 2026, with employment types broken down into 90% Full Time, and 10% Temporary. Highlights an 83% Physical, 2% Hybrid, and 15% Remote job distribution, with an average salary of $77,940 per year, or $37.5 per hour.

Senior Equity Analyst

South Florida Search Partners

Miami, FL • On-site

Other

This job post has expired 1 day ago. Applications are no longer accepted.

Job description

About the Firm

This is the public equities investment arm of a private conglomerate with well over 100 years of history and a long tradition of patient, high-conviction capital allocation across its operating businesses.

The team is intentionally small and flat. The Senior Analyst will work directly alongside the Portfolio Manager and will be a meaningful voice in the investment process from day one.


The Strategy

Invest in high quality businesses with durable competitive advantages — moats that have typically taken five to ten years to develop and that are expected to persist and strengthen over time. Concentrated, (<20), predominantly US mid/large cap

Sector focus: Aerospace & Defense, Healthcare (excluding Pharmaceuticals and Biotech), Industrials (excluding commodity-linked businesses), and Consumer with an emphasis on luxury and durable brand franchises.

Turnover is low by design. Volatility is not treated as risk. Permanent impairment of capital is.


The Role

  • Deep fundamental research on current holdings and the watchlist — filings, transcripts, industry publications, and competitive dynamics, filtered through a long-term lens rather than a news cycle
  • Financial modeling, accounting analysis, and valuation work — including cash flow quality, working capital dynamics, accruals, footnote review, and capital allocation history
  • Tariff and trade policy exposure analysis, supply chain geography, sourcing dependencies, pricing power pass-through, and margin sensitivity; structural, off- book analysis that materially affects long-term intrinsic value
  • Daily collaboration with the Portfolio Manager on portfolio construction, position sizing, risk/reward assessment, and management engagement
  • Thoughtful application of large language models and agentic AI tools as a research force multiplier


  • Qualifications
  • Approx 5 years of fundamental research experience at a long/short hedge fund, concentrated long- only fund, private equity firm, or private credit fund
  • Strong accounting, corporate finance, and valuation skills
  • Demonstrated ability to assess business quality, competitive positioning, and long-term earnings power
  • Comfort with concentration, long duration, and a low-turnover investment philosophy
  • Excellent written and verbal communication skills
  • Open-minded approach to AI and large language models, with the critical judgment to apply them effectively


  • What Makes This Role Distinctive
  • A platform built to manage significant public equity capital over time, with full portfolio independence and the full backing of a parent organization whose vast global relationships and deep industry presence are a structural research advantage
  • A no-blame culture — rigorous process is valued over outcome; intellectual honesty and the willingness to update a thesis are expected and respected
  • Patient capital base


If you want to help build a research-intensive investment firm from first principles — and grow with it for years — we want to talk with you.

Apply